Factors that predict pursuing sinus surgery in the era of highly effective modulator therapy
International Forum of Allergy & Rhinology · 2024
DOI: 10.1002/alr.23270 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Forum of Allergy & Rhinology, 2024. Verfasst von Daniel M Beswick und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head and Neck Surgery, University of California, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, Rhinitis, Paranasal Sinuses, Sinusitis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Cystic Fibrosis Foundation.
Abstract (Originalsprache)
Background
Comorbid chronic rhinosinusitis (CRS) remains unresolved for many people with cystic fibrosis (PwCF). While highly effective modulator therapy improves quality‐of‐life and symptom severity, the impact of this intervention and other factors associated with pursuing endoscopic sinus surgery (ESS) remains understudied.
Methods
Adult PwCF + CRS were enrolled into a prospective, observational, multi‐institutional study. Participants completed validated outcome measures to evaluate respiratory symptom severity, depression, headache, and sleep quality, as well as nasal endoscopy, sinus computed tomography (CT), and olfactory testing. Bivariate comparisons and regression modeling evaluated treatment cofactors, disease characteristics, and outcome measures associated with pursuing ESS.
Results
Sixty PwCF were analyzed, including 24 (40%) who elected ESS. Pursuing ESS was associated with worse SinoNasal Outcome Test (SNOT‐22) total, rhinologic, psychological, and sleep dysfunction domain scores; worse Patient Health Questionnaire‐9‐Revised depression scores; worse Pittsburgh Sleep Quality Index total scores; worse weight, role, emotion, and eating domain scores on the Cystic Fibrosis Questionnaire‐Revised; more severe disease on nasal endoscopy; and lack of modulator therapy (all p < 0.050). Multivariable regression identified that worse SNOT‐22 total score was associated with electing ESS (odds ratio [OR] 1.09, 95% confidence interval [CI] 1.02–1.16, p = 0.015) and elexacaftor/tezacaftor/ivacaftor (ETI) treatment (OR 0.04, 95% CI 0.004–0.34, p = 0.004) was associated with pursing medical therapy.
Conclusions
Worse sinonasal symptom burden, lack of ETI treatment, sleep quality, depression, and nasal endoscopy scores were associated with electing ESS, while lung disease severity and sinus CT scores were not. ETI use was associated with lower odds of pursuing ESS independent of sinonasal symptom burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Head and Neck Surgery, University of California, Los Angeles, California, USA.
- Department of Otolaryngology-Head and Neck Surgery, Oregon Health Sciences University, Portland, Oregon, USA.
- CTSI, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
- Department of Otolaryngology-Head and Neck Surgery, University of Utah, Salt Lake City, Utah, USA.
- Department of Psychology, Portland State University, Portland, Oregon, USA.
- Department of Otolaryngology-Head and Neck Surgery, Vanderbilt Health, Nashville, Tennessee, USA.
ORCID-Profile: Daniel M Beswick, Ethan J Han, Karolin Markarian, Jeremiah A Alt, Peter H Hwang, Ashoke Khanwalkar, Jayakar V Nayak, Zara Patel, Timothy L Smith
Förderung
- Cystic Fibrosis Foundation
Zitieren
APA
Beswick, D. M., Han, E. J., Mace, J. C., Markarian, K., Alt, J. A., Bodner, T. E., Chowdhury, N. I., Eshaghian, P. H., Getz, A. E., Hwang, P. H., Khanwalkar, A., Kimple, A. J., Lee, J. T., Li, D. A., Norris, M., Nayak, J. V., Owens, C., Patel, Z., Poch, K., …, & Saavedra, M. (2024). Factors that predict pursuing sinus surgery in the era of highly effective modulator therapy. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.23270
Vancouver
Beswick DM, Han EJ, Mace JC, Markarian K, Alt JA, Bodner TE, et al. Factors that predict pursuing sinus surgery in the era of highly effective modulator therapy. International Forum of Allergy & Rhinology. 2024. doi:10.1002/alr.23270
BibTeX
@article{Beswick2024,
author = {Beswick, Daniel M and Han, Ethan J and Mace, Jess C and Markarian, Karolin and Alt, Jeremiah A and Bodner, Todd E and Chowdhury, Naweed I and Eshaghian, Patricia H and Getz, Anne E and Hwang, Peter H and Khanwalkar, Ashoke and Kimple, Adam J and Lee, Jivianne T and Li, Douglas A and Norris, Meghan and Nayak, Jayakar V and Owens, Cameran and Patel, Zara and Poch, Katie and Schlosser, Rodney J and Smith, Kristine A and Smith, Timothy L and Soler, Zachary M and Suh, Jeffrey D and Turner, Grant and Wang, Marilene B and Taylor-Cousar, Jennifer L and Saavedra, Milene},
title = {Factors that predict pursuing sinus surgery in the era of highly effective modulator therapy},
journal = {International Forum of Allergy & Rhinology},
year = {2024},
doi = {10.1002/alr.23270}
}
EUVIMED